Controllability of human cancer signaling network

Biological processes embody molecular regulatory mechanisms equivalent to the notion of signaling used in engineering. Using signaling as a paradigm, we constructed human cancer signaling network embodying empirically reported molecular mechanisms underlying cancer. We further identified driver nodes and classified them based on their role in structural controllability of this network. We hypothesize that nodes that are critical for achieving centralized control are therapeutically important. We observed that anti-cancer drugs primarily act through such genes that serve as their targets. Despite significant differences between networked systems in engineering, for which structural controllability has been traditionally designed, we present a study that reveals its utility for analysis of disease networks with therapeutic implications.

[1]  A. Lombardi,et al.  Controllability analysis of networks. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.

[2]  Albert-László Barabási,et al.  Control Principles of Complex Networks , 2015, ArXiv.

[3]  Albert-László Barabási,et al.  Controllability of complex networks , 2011, Nature.

[4]  Tamás Vicsek,et al.  Controlling edge dynamics in complex networks , 2011, Nature Physics.

[5]  Joshua F. McMichael,et al.  DGIdb - Mining the druggable genome , 2013, Nature Methods.

[6]  A. Barabasi,et al.  Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets , 2015, Proceedings of the National Academy of Sciences.

[7]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[8]  Tatsuya Akutsu,et al.  Structurally robust control of complex networks. , 2014, Physical review. E, Statistical, nonlinear, and soft matter physics.

[9]  Ching-tai Lin.  Structural controllability , 1974 .

[10]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[11]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[12]  Rahul Sarpeshkar,et al.  Synthetic analog computation in living cells , 2013, Nature.

[13]  Linqiang Pan,et al.  Identifying Driver Nodes in the Human Signaling Network Using Structural Controllability Analysis , 2015, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[14]  M. Uhart,et al.  Controllability of protein-protein interaction phosphorylation-based networks: Participation of the hub 14-3-3 protein family , 2016, Scientific Reports.

[15]  D. Bray.  Protein molecules as computational elements in living cells , 1995, Nature.

[16]  Stefan Wuchty,et al.  Controllability in protein interaction networks , 2014, Proceedings of the National Academy of Sciences.

[17]  Simo V. Zhang,et al.  A map of human cancer signaling , 2007, Molecular systems biology.

[18]  Tatsuya Akutsu,et al.  Dominating scale-free networks with variable scaling exponent: heterogeneous networks are not difficult to control , 2012 .

[19]  E D Sontag,et al.  Some new directions in control theory inspired by systems biology. , 2004, Systems biology.

[20]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[21]  Endre Csóka,et al.  Emergence of bimodality in controlling complex networks , 2013, Nature Communications.